By now, we’ve all heard about the importance of cancer screening. But for those with a detected cancer, a new article highlights that the removal of the malignancy might not be where you should stop in your health journey.
Cancer Center | 
September 18, 2020
While many cancer types have added new treatments including genetically targeted drugs and immunotherapies, treatment for the rare types of cancer known as sarcomas have remained largely the same for about two decades. Now, two grants to University of Colorado Cancer Center researchers from the Sarcoma Foundation of America hope to change this.
Cancer Center | June 22, 2020
U.S. News and World Report (USNWR) released its 2020-21 Best Children’s Hospitals rankings this week. In the category of best hospitals for pediatric cancer, Children’s Hospital Colorado was ranked ninth in the country. Pediatric cancer services are provided by University of Colorado (CU) School of Medicine faculty who many are members of the CU Cancer Center.
Cancer Center | June 19, 2020
Cure Today
December 24, 2020
It is one of the most common types of leukemias in adults; however, the disease comprises only about 1% of all cancers. There are a variety of treatment options available for patients with AML, with more clinical trials evaluating new therapies in the pipeline. In this episode of the “CURE talks Cancer” podcast, we spoke with Dan Pollyea, from the University of Colorado Cancer Center, about these treatment options.
Fox 31 | Channel 2
October 06, 2020
Mia and her parents shared their experience with RadFlix with FOX31. They explained that watching TV or a movie while getting radiation treatment was a game-changer. RadFlix was developed by Douglas Holt, MD, Brian Miller, PhD, and Sarah Milgrom, MD.
CBS4 Denver
October 05, 2020
Bucky Dilts, former Denver Broncos and prostate cancer survivor, and Dr. Paul Maroni, shared with CBS Denver why men should be getting a prostate cancer screening.
OncLive
August 25, 2020
Erin Schenk, MD, PhD, University of Colorado Cancer Center member, discusses the rapidly evolving treatment landscape in lung cancer.
